Tolerance in Organ Transplantation: From Conventional Immunosuppression to Extracellular Vesicles

Organ transplantation is often the unique solution for organ failure. However, rejection is still an unsolved problem. Although acute rejection is well controlled, the chronic use of immunosuppressive drugs for allograft acceptance causes numerous side effects in the recipient and do not prevent chr...

Full description

Bibliographic Details
Main Authors: Monguió-Tortajada, Marta, Lauzurica-Valdemoros, Ricardo, Borràs, Francesc E.
Format: Online
Language:English
Published: Frontiers Media S.A. 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166341/
id pubmed-4166341
recordtype oai_dc
spelling pubmed-41663412014-10-02 Tolerance in Organ Transplantation: From Conventional Immunosuppression to Extracellular Vesicles Monguió-Tortajada, Marta Lauzurica-Valdemoros, Ricardo Borràs, Francesc E. Immunology Organ transplantation is often the unique solution for organ failure. However, rejection is still an unsolved problem. Although acute rejection is well controlled, the chronic use of immunosuppressive drugs for allograft acceptance causes numerous side effects in the recipient and do not prevent chronic allograft dysfunction. Different alternative therapies have been proposed to replace the classical treatment for allograft rejection. The alternative therapies are mainly based in pre-infusions of different types of regulatory cells, including DCs, MSCs, and Tregs. Nevertheless, these approaches lack full efficiency and have many problems related to availability and applicability. In this context, the use of extracellular vesicles, and in particular exosomes, may represent a cell-free alternative approach in inducing transplant tolerance and survival. Preliminary approaches in vitro and in vivo have demonstrated the efficient alloantigen presentation and immunomodulation abilities of exosomes, leading to alloantigen-specific tolerance and allograft acceptance in rodent models. Donor exosomes have been used alone, processed by recipient antigen-presenting cells, or administered together with suboptimal doses of immunosuppressive drugs, achieving specific allograft tolerance and infinite transplant survival. In this review, we gathered the latest exosome-based strategies for graft acceptance and discuss the tolerance mechanisms involved in organ tolerance mediated by the administration of exosomes. We will also deal with the feasibility and difficulties that arise from the application of this strategy into the clinic. Frontiers Media S.A. 2014-09-17 /pmc/articles/PMC4166341/ /pubmed/25278936 http://dx.doi.org/10.3389/fimmu.2014.00416 Text en Copyright © 2014 Monguió-Tortajada, Lauzurica-Valdemoros and Borràs. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Monguió-Tortajada, Marta
Lauzurica-Valdemoros, Ricardo
Borràs, Francesc E.
spellingShingle Monguió-Tortajada, Marta
Lauzurica-Valdemoros, Ricardo
Borràs, Francesc E.
Tolerance in Organ Transplantation: From Conventional Immunosuppression to Extracellular Vesicles
author_facet Monguió-Tortajada, Marta
Lauzurica-Valdemoros, Ricardo
Borràs, Francesc E.
author_sort Monguió-Tortajada, Marta
title Tolerance in Organ Transplantation: From Conventional Immunosuppression to Extracellular Vesicles
title_short Tolerance in Organ Transplantation: From Conventional Immunosuppression to Extracellular Vesicles
title_full Tolerance in Organ Transplantation: From Conventional Immunosuppression to Extracellular Vesicles
title_fullStr Tolerance in Organ Transplantation: From Conventional Immunosuppression to Extracellular Vesicles
title_full_unstemmed Tolerance in Organ Transplantation: From Conventional Immunosuppression to Extracellular Vesicles
title_sort tolerance in organ transplantation: from conventional immunosuppression to extracellular vesicles
description Organ transplantation is often the unique solution for organ failure. However, rejection is still an unsolved problem. Although acute rejection is well controlled, the chronic use of immunosuppressive drugs for allograft acceptance causes numerous side effects in the recipient and do not prevent chronic allograft dysfunction. Different alternative therapies have been proposed to replace the classical treatment for allograft rejection. The alternative therapies are mainly based in pre-infusions of different types of regulatory cells, including DCs, MSCs, and Tregs. Nevertheless, these approaches lack full efficiency and have many problems related to availability and applicability. In this context, the use of extracellular vesicles, and in particular exosomes, may represent a cell-free alternative approach in inducing transplant tolerance and survival. Preliminary approaches in vitro and in vivo have demonstrated the efficient alloantigen presentation and immunomodulation abilities of exosomes, leading to alloantigen-specific tolerance and allograft acceptance in rodent models. Donor exosomes have been used alone, processed by recipient antigen-presenting cells, or administered together with suboptimal doses of immunosuppressive drugs, achieving specific allograft tolerance and infinite transplant survival. In this review, we gathered the latest exosome-based strategies for graft acceptance and discuss the tolerance mechanisms involved in organ tolerance mediated by the administration of exosomes. We will also deal with the feasibility and difficulties that arise from the application of this strategy into the clinic.
publisher Frontiers Media S.A.
publishDate 2014
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166341/
_version_ 1613134648327536640